Found 7 matching trials
A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial
PHASE2This phase IIA trial studies the effect of a vaccine (PDS0101) when given t...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
PHASE3This is a global, multi-center, Phase 3 study that is randomized 1:1, contr...
Status
Active Not Recruiting
Location
Mayo Clinic Arizona
Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC
PHASE2VERSATILE-002 is a Phase 2, open-label, multicenter study of the efficacy a...
Location
Marin Cancer Center
CASCADE: Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV
PHASE2This study is testing the immunotherapeutic agent, PDS0101, in adults livin...
Location
Weill Cornell Medical College
An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101
PHASE1Phase I, open-label, sequential-cohort, ascending multiple-dose study to ev...
Location
Suffolk Obstetrics & Gynecology
Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies
PHASE1Background:
More than 30,000 cases of human papillomavirus (HPV) associate...
Location
National Institutes of Health Clinical Center
A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer
PHASE1This phase I/II trial studies how well PDS0101 alone or in combination with...
Status
Active Not Recruiting
Location
Mayo Clinic in Rochester